In addition, acetylcholinesterase and a-glucosidase are key targets for the treatment of Alzheimer’s disease and diabetes mellitus, but clinically useful drugs such as acarbose, tacrine, and voglibose are expensive and have serious side effects. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.